AUG 13, 2026 · PHASE 2/3 TRIAL
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
ClinicalTrials.gov
This is a recruiting Phase 2/3 trial registration with no reported results; primary outcomes remain unassessed and data are not yet available to evaluate efficacy or safety.
Reported
Planned enrollment1580
Phase 2 primary endpoint (safety)Treatment-emergent adverse events (TEAE) in…
Phase 2 primary endpoint (efficac…Objective response rate (ORR) and best perc…